Viruses and Atherosclerosis: Do They Play a Pathogenic Role?

Osler W , editor. Modern medicine. Its theory and practice. Vol. IV. Philadelphia and New York: Lea & Lebiger, 1908: 427–46.

Saikku P . Chlamydia pneumoniae and atherosclerosis-an update. Scand J Infect Dis 1997;104(Suppl):53–6.

Mattila KJ , Valtonen VV , Nieminen MS . Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719–34.

Gupta S , Camm AJ . Chronic infection in the etiology of athero-sclerosis-the case for Chlamydia pneumoniae. Clin Cardiol 1997:20:829–36.

Mehta JL , Saldeen TGP , Rand K . Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998;31:1217–25.

Muhlestein JB , Hammond EH , Carlquist JF , Radicke E , Thomson MJ , Karagounis LA , Woods ML , Anderson JL . Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555–61.

Phinney P , Fligiel S , Bryson Y , Porter D . Necrotizing vasculitis in a case of disseminated neonatal herpes simplex infection. Arch Pathol Lab Med 1982;106:64–7.

Paterson JC , Cottral GE . Experimental coronary sclerosis, III: lymphomatosis as a cause of coronary sclerosis in chickens. Arch Pathol 1950;49:669–707.

Fabricant CG , Fabricant J , Litrenta M , Minick C . Virus induced atherosclerosis. J Exp Med 1978;148:335–40.

Minick CR , Fabricant CG , Fabricant J , Litrenta MM . Atheroarteriosclerosis induced by infection by herpesvirus. Am J Pathol 1978;96:673–706.

Peersoons MCJ , Daemen MJAP , Bruning JH , Bruggeman CA . Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats: a clue to herpes virus-associated atherogenesis. Circ Res 1994;75:214–20.

Benditt EP , Benditt JM . Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753–6.

Benditt E , Barrett T , McDougall J . Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983;80:6386–9.

Melnick J , Dreesman G , McCollum C , Petrie B , Burek J , DeBakey M . Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;2:644–6.

Yamashiroya H , Ghosh L , Yang R , Robertson . Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988;130:71–9.

Gyorkey F , Melnick J , Guinn G , Gyorkey P , DeBakey M . Herpes viridae in endothelial cells of the proximal aorta of atherosclerotic patients. Exp Mol Pathol 1984;40:328–39.

Hendrix M , Salimans M , van Boven C , Bruggeman C . High prevalence of latently present cytomegalovirus in artery walls of patients suffering grade III atherosclerosis. Am J Pathol 1990;136:23–8.

Adam E , Melnick J , Probesfield J , Petrie B , Burek J , Bailey K , McColum C , DeBakey M . High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2:291–3.

Sorlie PD , Adam E , Melnick SL , Folsom A , Skelton T , Chambless LE , Barnes R , Melnick SL (for the ARIC Study Investigators). Cytomegalovirus/herpesvirus and carotid atherosclerosis: The ARIC Study. J Med Virol 1994;42:33–7.

Chiu B , Viira E , Tucker W , Fong IW . Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 197;96:2144–8.

Nieto FJ , Sorlie P , Comstock GW , Wu K , Adam E , Melnick JL , Szklo M . Cytomegalovirus infection, lipoprotein (a), and hypercoagulability: an atherogenic link? Arterioscl, Thromb Vasc Biol 1997;17(9):1780–5.

Havlik R , Blackwelder W , Kaslow R , Castelli W . Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages: the Framingham Heart Study. Arteriosclerosis 1989;9:877–80.

Kol A , Sperti G , Shani J , Schulhoff N , van de Greef W , Landini MP , La Placa M , Maseri A , Crea F . Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995;91:1910–3.

Grattan M , Moreno-Cabral C , Starnes V , Oyer P , Stinson E , Shumway N . Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561–6.

McDonald K , Rector T , Braunlan E , Coubo S , Olivari M . Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Pathol 1989;64:359–62.

Gulizia J , Kandolf R , Kendall T , Thieszen S , Wilson J , Radio S , Costanzo M , Winters G , Miller L , McManus B . Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995;147:461–75.

Skowronski E , Mendoza A , Smith S , Jaski B . Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: implications of cytomegalovirus association with graft atherosclerosis. J Heart Lung Transplant 1993;12:717–23.

Hosenpud J , Chou S , Wagner W . Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991;52:896–903.

Ustinov J , Kognov R , Bruggeman C , van der Meide P , Hayry P , Lautenschlager I . Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart-Lung Transplant 1993; 12:644–51.

Sedmak DD , Guglielmo AM , Knight DA , Birmingham DJ , Huang EH , Waldman WJ . Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol 1994; 144:683–92.

Bruggeman CA , van Dam-Mieras MCE . The possible role of cytomegalovirus in atherogenesis. In: Melnick JL , ed. Prog Med Virol. Basel: Karger, 1991;38:1–26.

Sedmak DD , Knight DA , Vook NC , Waldman WJ . Divergent patterns of ELAM-1, ICAM-1 and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994;58:1379–85.

Lemstrom K , Aho P , Bruggeman C , Hayry P . Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Arterioscler Thromb 1994;14:2043–52.

Speir E , Shibutani T , Yu Z , Ferrans V , Epstein S . Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res 1996;79:1143–52.

Vossen RCRM , van Dam-Mieras MCE , Bruggeman CA . Cytomegalovirus infection and vessel wall pathology. Intervirology 1996;39:213–21.

Yurochko AD , Kowalik TF , Huong SM , Huang ES . Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995;69(9):5391–400.

Zhou Y , Leon M , Maclawiw M , Popma J , Yu Z , Finkel T , Epstein S . Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624–30.

Blum A , Giladi M , Weinberg M , Kaplan G , Pasternack H , Laniado S , Miller H . High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998;81:866–8.

Libby P , Schwartz D , Brogi E , Tanaka H , Clinton S . A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 1992; 86(Suppl III):III-47 - III-52.

Speir E , Modali R , Huang E , Leon M , Shawl F , Finkel T , Epstein S . Potential role of human cytomegalovirus and p53 interaction in coronary atherosclerosis. Science 1994;265:391–4.

Zhu H , Shen Y , Shenk T . Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995;69:7960–70.

Kovacs A , Weber M , Burns L , Jacob H , Vercellotti G . Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am J Pathol 1997;149:1531–9.

Moldow CF , Vercellotti GM . Herpesvirus effects on proinflammatory and procoagulant properties of endothelial cells. In: Hajjar D , Schwartz S eds. The role of vascular viral infections in atherosclerosis. Chur, Switzerland: Harwood Academic Publishers. In press.

Melnick JL , Adam E , DeBakey ME . Cytomegalovirus and atherosclerosis. BioEssays 1995;17:899–903.

Nicholson AC , Hajjar DP . Herpesvirus in atherosclerosis and thrombosis. Etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998;18:339–48.

Vercellotti GM . Potential role of viruses in thrombosis and atherosclerosis. Trends Cardiovasc Med 1995;5:128–33.

Visser M , Vercellotti G . Herpes simplex virus and atherosclerosis. Eur Heart J 1993;14(Suppl K):39–42.

Hajjar D . Viral pathogenesis of atherosclerosis: impact of molecular mimicry and viral genes. Am J Pathol 1991;139:1195–1211.

Macgregor RR , Friedman HM , Macarak EJ , Kefalides NA . Virus infection of endothelial cells increases granulocyte adherence. J Clin Invest 1980;65:1469–77.

Visser M , Jacob H , Goodman J , McCarthy J , Furcht L , Vercellotti G . Granulocyte-mediated injury to herpes simplex virus-infected human endothelium. Lab Invest 1989;60:296–304.

Span A , van Boven C , Bruggeman C . The effect of cytomegalovirus infection on the adherence of polymorphonuclear leukocytes to endothelial cells. Eur J Clin Invest 1989; 19:542–8.

Cines DB , Lyss AP , Bina M , Corkey R , Kefalides NA . Fc and C3 receptors induced by Herpes simplex virus infection in cultured endothelial cells. J Clin Invest 1982;69:123–8.

Etingin O , Silverstein R , Hajjar D . Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc Natl Acad Sci USA 1991;88:7200–3.

van Dam-Mieras M , Muller A , van Hinsbergh V , Mullers W , Bomans P , Bruggeman C . The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 1992;68:364–70.

Visser M , Tracy P , Vercellotti G , Goodman J , White J , Jacob H . Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci USA 1988;85:8227–30.

Pryzdial E , Wright J . Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994;84:3749–57.

Etingin O , Silverstein R , Friedman H , Hajjar D . Viral activation of the coagulation cascade: molecular interactions at the surface of the infected endothelial cell. Cell 1990;61;657–62.

Altieri D , Etingin O , Fair D , Brunck T , Geltosky J , Hajjar D , Edgington T . Structural homologous ligand binding of integrin mac-1 and viral glycoprotein C receptors. Science 1991; 254:1200–3.

Key N , Bach R , Vercellotti G , Moldow C . Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. Lab Invest 1993;68:645–51.

Kaner R , Iozzo R , Ziaie Z , Kefalides N . Inhibition of proteoglycan synthesis in human endothelial cells after infection with herpes simplex virus type 1 in vitro. Am J Respir Cell Mol Biol 1990;2:423–31.

Key N , Vercellotti G , Winkelmann J , Moldow C , Goodman J , Esmon N , Esmon C , Jacob H . Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 1990;87:7095–7.

Bok RA , Jacob HS , Balla J , Juckett M , Stilla T , Shatos MA , Vercellotti GM . Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor. Thromb Haemost 1993;69(3):253–8.

Etingin O , Silverstein R , Hajjar D . von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993;90:5153–6.

Hajjar D , Falcone D , Fabricant C , Fabricant J . Altered cholesteryl ester cycle is associated with lipid accumulation in herpesvirus-infected arterial smooth muscle cells. J Biol Chem 1985;260:6124–8.

Hajjar D . Herpesvirus infection prevents activation of cytoplasmic cholesteryl esterase in arterial smooth muscle cells. J Biol Chem 1986;261:7611–4.

Hajjar D , Nicholson A , Hajjar K , Sando G , Summers B . Decreased messenger RNA translation in herpesvirus-infected arterial cells: effects on cholesteryl ester hydrolase. Proc Natl Acad Sci USA 1989;86:3366–70.

Zhou Y , Guetta E , Yu Z , Finkel T , Epstein S . Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 1996;98:2129–38.

Libby P , Egan D , Skarlatos S . Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96;4095–103.

Mendall MA , Patel P , Ballam L , Strachan D , Northfield TC . C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996:212:1061–5.